Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
AMRO
|
April 8, 1992
Getting through: development of a communication strategy
F Whittle
British Journal of Hospital Medicine
|
June 1, 1989
The safety of cordocentesis
M F Whittle
Journal of Human Genetics
|
February 19, 2024
Leigh syndrome with developmental regression and ataxia due to a novel splicing variant in the PMPCB gene
Emma Matthews, Ella F Whittle, Faraan Khan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2022
Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities
Ella F Whittle, Madison Chilian, Ehsan Ghayoor Karimiani, et al.
JAMA Neurology
|
May 4, 2026
Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies
Emma Sherrill, David Cheerie, Cara J Beck, et al.
American Journal of Human Genetics
|
March 26, 2025
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments
David Cheerie, Margaret M Meserve, Danique Beijer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
AMRO
|
April 8, 1992
Getting through: development of a communication strategy
F Whittle
British Journal of Hospital Medicine
|
June 1, 1989
The safety of cordocentesis
M F Whittle
Journal of Human Genetics
|
February 19, 2024
Leigh syndrome with developmental regression and ataxia due to a novel splicing variant in the PMPCB gene
Emma Matthews, Ella F Whittle, Faraan Khan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2022
Biallelic variants in OGDH encoding oxoglutarate dehydrogenase lead to a neurodevelopmental disorder characterized by global developmental delay, movement disorder, and metabolic abnormalities
Ella F Whittle, Madison Chilian, Ehsan Ghayoor Karimiani, et al.
JAMA Neurology
|
May 4, 2026
Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies
Emma Sherrill, David Cheerie, Cara J Beck, et al.
American Journal of Human Genetics
|
March 26, 2025
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments
David Cheerie, Margaret M Meserve, Danique Beijer, et al.
Page
of 1